For instance, the presence of an IDH mutation may provide an opportunity to apply specific, IDH targeted treatment, no matter if the diagnosis was astrocytoma or (1p/19q codeleted) oligodendroglioma [15, 106]. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).